Last reviewed · How we verify

NCT06637696

The Effect of Implementation of Bundle for Preventing Blood Culture Contamination in Neonatal Intensive Care Unit

Completed NA Last updated 15 October 2024
What this trial tests

NA trial testing Blood Culture Bundle in Newborn; Infection in 320 participants. Completed in 31 May 2023.

Timeline
1 May 2022
Primary endpoint
31 May 2023
31 May 2023

Quick facts

Lead sponsorDr. Behcet Uz Children's Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingsingle
Primary purposediagnostic
Enrollment320
Start date1 May 2022
Primary completion31 May 2023
Estimated completion31 May 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Behcet Uz Children's Hospital

Who can join

Adults 1 Day to 28 Days, any sex, with Newborn; Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, investigators aimed to evaluate the impact of blood culture bundles on the incidence of contamination in the neonatal intensive care unit (NICU).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Dr. Behcet Uz Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06637696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing